Fennec Pharmaceuticals (FENC) Retained Earnings (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Retained Earnings came in at -$229.4 million in Q4 2025, down 4.43% YoY from -$240.1 million in Q4 2024, and down 18557.12% on a QoQ basis from $1.2 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Retained Earnings (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Retained Earnings data on file, last reported at -$229.4 million in Q4 2025.
- Quarterly Retained Earnings fell 4.43% year-over-year to -$229.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$229.4 million (down 4.43% YoY) and the FY2025 annual result came in at -$229.4 million, down 4.43% from the prior year.
- Retained Earnings declined to -$229.4 million in Q4 2025, from $1.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $215.6 million in Q3 2023 to a low of -$229.4 million in Q4 2025.
- A 5-year average of -$65.7 million and a median of $1.2 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings surged 209.81% — and 2024, when it tumbled 17773.45%.
- Tracing FENC's Retained Earnings over 5 years: stood at -$179.5 million in 2021, then soared by 100.69% to $1.2 million in 2022, then changed by 0.0% to $1.2 million in 2023, then plunged by 17773.45% to -$219.7 million in 2024, then decreased by 4.43% to -$229.4 million in 2025.
- The last three Retained Earnings figures came in at -$229.4 million (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | -227.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -227.25 Mn |
| Dec 31, 2025 | -229.42 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | -219.68 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | -206.41 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 215.61 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | -196.34 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Dec 31, 2021 | -179.49 Mn |
| Sep 30, 2021 | -175.06 Mn |
| Jun 30, 2021 | -170.90 Mn |